Last reviewed · How we verify
NCT05039853: IMPREL
Improving Mental Health Following Early PREgnancy Loss Using a Brief Cognitive Task
NA trial testing Brief cognitive task-based intervention in Post-traumatic Stress Disorder in 168 participants. Completed in 1 June 2024.
21 March 2024
Quick facts
| Lead sponsor | Imperial College London |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 168 |
| Start date | 9 December 2021 |
| Primary completion | 21 March 2024 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Brief cognitive task-based intervention
- Placebo activity
Conditions studied
- Post-traumatic Stress Disorder — all drugs for Post-traumatic Stress Disorder →
- Miscarriage — all drugs for Miscarriage →
- Ectopic Pregnancy — all drugs for Ectopic Pregnancy →
- Pregnancy Loss — all drugs for Pregnancy Loss →
Sponsor
Imperial College London
Who can join
18 and older, female only, with Post-traumatic Stress Disorder or Miscarriage. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomised controlled trial designed to investigate the impact of a brief-cognitive task based intervention on intrusive memories, mental health symptoms and daily functioning, in women following an early pregnancy loss.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05039853
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post-traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06943404 — BXCL501 After Stress to Increase Recovery Success · Phase 2 · recruiting
- NCT06477796 — Improving Sleep in Veterans With the Polytrauma Clinical Triad · NA · recruiting
- NCT06538246 — Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors · NA · recruiting
- NCT06592677 — Early Support After Exposure to Trauma · NA · recruiting
- NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
Other Imperial College London trials
Trials by the same sponsor.
- NCT06035861 — Endothelial Cell Activation and Total Pulmonary Resistance in PAH · NA · not yet recruiting
- NCT07397455 — Development of a Controlled Human Infection Model for Assessment of SARS-CoV-2 Omicron Subvariants · Phase 1 · not yet recruiting
- NCT07422532 — A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing · NA · not yet recruiting
- NCT07389031 — Maralixibat for Intrahepatic Cholestasis of Pregnancy · Phase 2 · not yet recruiting
- NCT07358897 — Gender Affirming Hormone Therapy and Immune Function in Trans Individuals - The GIFT Study · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05039853 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Imperial College London
- Last refreshed: 29 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05039853.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing